Financials

News Discussions Technicals Forecast Seasonals

BMX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Biomaxima SA operates in the field of biotechnology and laboratory diagnostics. It offers diagnostic reagents to study biochemical parameters of blood and other body fluids including analyzers, rapid diagnostic tests for the detection of infectious diseases, tumor markers, markers of myocardial infarction, and drugs. The firm also produces systems for analyzing urine, hematology reagents, and blood analyzers. The company was founded in 1997 and is headquartered in Lublin, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

BMX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company